You are here

Otonomy

Otonomy fails phase 3, adding another twist to ear disease saga

Otonomy fails phase 3, adding another twist to ear disease saga

Fierce Biotech

clinical trials

Meniere's Disease

Flag link:

Otonomy shares surge on positive Ménière's data

Otonomy shares surge on positive Ménière's data

BioPharma Dive

Meniere's Disease

clinical trials

Flag link:

Otonomy brings out the ax after a catastrophic PhIII failure

Otonomy brings out the ax after a catastrophic PhIII failure

Endpoints

Meniere's Disease

clinical trials

Flag link:

Otonomy staggered by an ugly PhIII failure for lead pipeline drug

Otonomy staggered by an ugly PhIII failure for lead pipeline drug

Endpoints

clinical trials

Meniere's Disease

Flag link:

Otonomy wins FDA approval for a first-of-its-kind ear treatment

Otonomy wins FDA approval for a first-of-its-kind ear treatment

Fierce Biotech

Flag link:

Otonomy heads to the clinic with a tinnitus drug

Otonomy heads to the clinic with a tinnitus drug

Fierce Biotech

Flag link:

Otonomy Inc's ear drug fails mid-stage trial

Otonomy Inc's ear drug fails mid-stage trial

Yahoo/Reuters

Meniere's Disease

Flag link:

2014's most successful biotech IPOs

2014's most successful biotech IPOs

Fierce Biotech

Auspex Pharmaceuticals

Avalanche Biotechnologies

SAGE Therapeutics

Flag link:

Otonomy heads to the FDA after its ear treatment clears Phase III

Otonomy heads to the FDA after its ear treatment clears Phase III

Fierce Biotech

Flag link: